Related references
Note: Only part of the references are listed.The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma
Tong Sun et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2020)
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features
Bradley A. McGregor et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Escudier et al.
ANNALS OF ONCOLOGY (2019)
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
Nieves Martinez Changa et al.
LANCET ONCOLOGY (2019)
Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes
Yasser Ged et al.
CLINICAL GENITOURINARY CANCER (2019)
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series
Jozefina Casuscelli et al.
CLINICAL GENITOURINARY CANCER (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma
Bimal Bhindi et al.
EUROPEAN UROLOGY (2019)
A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Noneclear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus
Inkeun Park et al.
CLINICAL GENITOURINARY CANCER (2018)
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
A. Mejean et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma
Carmen Priolo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Go Noguchi et al.
BMC UROLOGY (2018)
Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study
Ki Sun Jung et al.
CANCER RESEARCH AND TREATMENT (2018)
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)
Christopher J. Ricketts et al.
CELL REPORTS (2018)
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma
Rana R. McKay et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
Vadim S. Koshkin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis
Matthew T. Campbell et al.
EUROPEAN JOURNAL OF CANCER (2018)
Cabozantinib for the treatment of kidney cancer
Ahmed Abdelaziz et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Renal Mass and Localized Renal Cancer: AUA Guideline
Steven Campbell et al.
JOURNAL OF UROLOGY (2017)
Rapid Response to Nivolumab in a Patient With Sarcomatoid Transformation of Chromophobe Renal Cell Carcinoma
Keren Rouvinov et al.
CLINICAL GENITOURINARY CANCER (2017)
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas
Mianen Sun et al.
CANCER RESEARCH (2017)
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study
Sebastiano Buti et al.
CLINICAL GENITOURINARY CANCER (2017)
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
Nizar M. Tannir et al.
EUROPEAN UROLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Martin H. Voss et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B. Haas et al.
LANCET (2016)
Everolimus versus sunitinib for patients with metastatic non-clear-cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Andrew J. Armstrong et al.
LANCET ONCOLOGY (2016)
Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas
Scott M. Haake et al.
MOLECULAR CANCER RESEARCH (2016)
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
Fengju Chen et al.
CELL REPORTS (2016)
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma
Yu-Zheng Ge et al.
SCIENTIFIC REPORTS (2015)
Renal Cell Carcinoma in Tuberous Sclerosis Complex
Ping Yang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
PD-L1 expression in nonclear-cell renal cell carcinoma
T. K. Choueiri et al.
ANNALS OF ONCOLOGY (2014)
Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)
Ayal A. Aizer et al.
BJU INTERNATIONAL (2014)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?
Keng Lim Ng et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma
Y. Koh et al.
ANNALS OF ONCOLOGY (2013)
Germline PTEN Mutation Cowden Syndrome: An Underappreciated Form of Hereditary Kidney Cancer
Brian Shuch et al.
JOURNAL OF UROLOGY (2013)
Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT
Jonathan R. Young et al.
RADIOLOGY (2013)
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series
Alessandro Volpe et al.
BJU INTERNATIONAL (2012)
A Phase 2 Trial of Sunitinib in Patients with Advanced Non-clear Cell Renal Cell Carcinoma
Nizar M. Tannir et al.
EUROPEAN UROLOGY (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Spectrum of somatic mitochondrial mutations in five cancers
Tatianna C. Larman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Birt-Hogg-Dube syndrome: diagnosis and management
Fred H. Menko et al.
LANCET ONCOLOGY (2009)
Differences in organ system of distant metastasis by renal cell carcinoma subtype
Nathan E. Hoffmann et al.
JOURNAL OF UROLOGY (2008)
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Use of Von-Hippel Lindau (VHL) mutation status to predict objective response to vascular endothelial growth factor (VEGF) - targeted therapy in metastatic renal cell carcinoma (RCC)
T. K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: The M.D. Anderson cancer center experience
Wassim Kassouf et al.
UROLOGY (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of incidental detection for survival of patients with renal cell carcinoma: Results of population-based study of 701 patients
T Gudbjartsson et al.
UROLOGY (2005)
How I do it: Evaluating renal masses
GM Israel et al.
RADIOLOGY (2005)
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
RC Flanigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
